Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

WISP-1 attenuates p53-mediated apoptosis

Feb. 14, 2002

Modulators of nuclear hormone receptors described in BMS patent

Feb. 14, 2002

Clinical program for Onco TCS expanded

Feb. 14, 2002

Twelve-month results from phase III trial of Metvix PDT in basal cell carcinoma

Feb. 14, 2002

British Biotech obtains European development & commercialization rights to MG-98

Feb. 14, 2002

Genta initiates two trials of Genasense in combination with chemotherapy in AML and SCLC

Feb. 14, 2002

Aurora2 kinase inhibitors patented by AstraZeneca

Feb. 13, 2002

Glycolipid derivatives claimed for use as antitumor agents and immunostimulants

Feb. 13, 2002

Yamanouchi synthesizes macrocyclic antitumor agents

Feb. 13, 2002

Estramustine analogues have a promising preclinical profile of antitumor activity

Feb. 13, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...